SEC EDGAR · Company announcement
TDG: Other company developments
Filed 8-K for an event or period dated 2026-07-10. Other company developments.
Follow TDG- Became public
- Jul 13, 2026, 6:45 AM EDT
- Event / period date
- Jul 10, 2026
- Collected
- Nov 9, 2026, 7:16 PM EST
Why this is connected
This filing identifies TransDigm Group INC as the issuer of the security. The company's SEC identifier connects it to TDG.
Source evidence
Read the source excerpt or record
Item 8.01. Other Events. On July 13, 2026, TransDigm Group Incorporated (the “Company”) announced that it has elected to withdraw from its proposed acquisition of Stellant Systems, Inc. (“Stellant”) from Arlington Capital Partners (“Seller”) and has notified relevant parties of its decision. The Company recently concluded, after careful consideration, that continuing to pursue the transaction through the regulatory review process was no longer in the best interests of the Company and its shareholders. In reaching this determination, the Company considered the uncertainty, the likely required time to complete the transaction relative to the contractual time limitation with Seller, and the opportunity cost of continuing to pursue the transaction rather than focusing on other strategic acquisition opportunities. Accordingly, the Company determined that withdrawing from the proposed acquisition represents the most prudent allocation of the Company's capital and management resources and is in the best interests of the Company and its shareholders. Following the Company's withdrawal of its regulatory filing on July 10, 2026, Seller provided the Company with notice of termination of the transaction agreement. The Company remains committed to its disciplined acquisition strategy and continues to evaluate acquisition opportunities that it believes will enhance long-term shareholder value. Forward-Looking Statements The statements in this Current Report on Form 8-K contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All forward-looking statements involve risks and uncertainties that could cause TransDigm Group’s actual results to differ materially from those expressed or implied in any forward-looking statements made by,
Congressional trading in TDG
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Sep 9, 2026$100K–$250K
Rep. April McClain Delaney (D-MD-6)
$100K–$250K · Traded Aug 25, 2026 · disclosed Sep 9, 2026 · Dependent
Committee overlap: Science - Aug 3, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Jul 28, 2026 · disclosed Aug 3, 2026 · Dependent
Committee overlap: ScienceTraded 7 days before earnings - Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
- Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 22, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 21, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 13, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 8, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 7, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.